Advertisement
For older adults starting antimuscarinic treatment for overactive bladder

Potentially Inappropriate Meds Use Common With OAB Tx

0
For older adults initiating antimuscarinic medication for overactive bladder, PIM is prevalent
The offspring of women using ondansetron early in pregnancy for nausea and vomiting of pregnancy or hyperemesis gravidarum may be at risk for cardiac abnormalities

Review: Low Risk of Birth Defects With Ondansetron Exposure

0
Ondansetron-exposed neonates may have small increase in incidence of cardiac abnormalities
Implementation of a computerized multidisciplinary order set in the electronic health record improves the quality of physician pharmacologic prescribing for patients hospitalized for chronic obstructive pulmonary disorder exacerbations

Computerized Order Set Aids Prescribing in COPD Exacerbations

0
Increase in percentage of patients receiving all recommended pharmacologic therapies
For most patients with chronic pancreatitis

Optimized Tx Linked to Lasting Pain Relief in Chronic Pancreatitis

0
Significant pain relief achieved in 84.7 percent of patients at one-year follow-up; most with medical tx
Clemastine fumarate partially reverses optic neuropathy in patients with multiple sclerosis

AAN: Antihistamine May Help Reverse Optic Neuropathy in MS

0
Vision improvement with clemastine fumarate appears modest but results are promising
Despite an increased proportion of Bordetella pertussis isolates lacking pertactin

Efficacy of DTaP, Tdap Holds Despite Pertactin Deficiency

0
Similar estimates for DTaP, Tdap VE to other settings, despite high prevalence of pertactin deficiency
Recommendations have been developed to increase human papillomavirus vaccine uptake

ASCO Presents Guidelines for Increasing HPV Vaccine Uptake

0
Oncologists should raise awareness of HPV-related cancers and role of vaccinations
There are no significant differences in occurrence of cardiovascular disease tied to treatment with glucagon-like peptide-1 receptor agonists compared with dipeptidyl peptidase-4 inhibitors

CV Risk Not Significantly Different for GLP-1 Receptor Agonists

0
Findings based on large study in real-world, head-to-head comparison of other drugs
Use of the word "breakthrough" in the U.S. Food and Drug Administration's expedited approval process could mislead doctors about the new drugs' actual benefits

Doctors Can Be Misled About FDA ‘Breakthrough’ Drug Designation

0
Many believe meds supported by stronger evidence than the law requires to achieve designation
The U.S. Preventive Services Task Force recommends aspirin use for primary prevention of cardiovascular disease and colorectal cancer in certain adults aged 50 to 69 years

USPSTF: Aspirin Recommended for Some Aged 50 to 69 Years

0
Benefits for primary prevention of CVD, CRC for certain adults aged 50 to 69 years